Patients play a crucial role in the Rare Tumor Initiative. Their participation in clinical trials and contribution to biobanks is essential for advancing research. The initiative emphasizes the importance of patient-centered research, ensuring that studies address the needs and concerns of those affected by rare tumors. By involving patients in the research process, the initiative not only accelerates scientific discovery but also empowers patients by providing them with access to cutting-edge treatments and clinical trials.
